278 related articles for article (PubMed ID: 33472220)
1. Safety and Outcomes of Transcatheter Closure of Patent Ductus Arteriosus in Children With Pulmonary Artery Hypertension.
Salavitabar A; Krishnan US; Turner ME; Vincent JA; Torres AJ; Crystal MA
Tex Heart Inst J; 2020 Aug; 47(4):250-257. PubMed ID: 33472220
[TBL] [Abstract][Full Text] [Related]
2. Contemporary outcomes of percutaneous closure of patent ductus arteriosus in adolescents and adults.
P S; Jose J; George OK
Indian Heart J; 2018; 70(2):308-315. PubMed ID: 29716712
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Bilici M; Demir F; Akın A; Türe M; Balık H; Kuyumcu M
Pediatr Cardiol; 2017 Dec; 38(8):1598-1605. PubMed ID: 28828684
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of transcatheter closure of large patent ductus arteriosus in adults with a self-expandable occluder.
Yu ML; Huang XM; Wang JF; Qin YW; Zhao XX; Zheng X
Heart Vessels; 2009 Nov; 24(6):440-5. PubMed ID: 20108077
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥16 mm).
Kanabar K; Bootla D; Kaur N; Pruthvi CR; Krishnappa D; Santosh K; Guleria V; Rohit MK
Indian Heart J; 2020; 72(2):107-112. PubMed ID: 32534682
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter occlusion of the patent ductus arteriosus in premature infants weighing less than 1200 g.
Morville P; Douchin S; Bouvaist H; Dauphin C
Arch Dis Child Fetal Neonatal Ed; 2018 May; 103(3):F198-F201. PubMed ID: 29066474
[TBL] [Abstract][Full Text] [Related]
8. Closure of very large PDA with pulmonary hypertension: Initial clinical case-series with the new Occlutech
Lehner A; Ulrich S; Happel CM; Fischer M; Kantzis M; Schulze-Neick I; Haas NA
Catheter Cardiovasc Interv; 2017 Mar; 89(4):718-725. PubMed ID: 27860161
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous device closure of patent ductus arteriosus with pulmonary artery hypertension: long-term results.
Vijayalakshmi IB; Setty N; Narasimhan C; Singla V; Manjunath CN
J Interv Cardiol; 2014 Dec; 27(6):563-9. PubMed ID: 25490863
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of patent ductus arteriosus: 11 years of clinical experience in Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Djer MM; Saputro DD; Putra ST; Idris NS
Pediatr Cardiol; 2015 Jun; 36(5):1070-4. PubMed ID: 25749918
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate?
Kumar SM; Subramanian V; Bijulal S; Krishnamoorthy KM; Sivasankaran S; Tharakan JA
Pediatr Cardiol; 2013 Oct; 34(7):1661-7. PubMed ID: 23591801
[TBL] [Abstract][Full Text] [Related]
12. Incidence and fate of device-related left pulmonary artery stenosis and aortic coarctation in small infants undergoing transcatheter patent ductus arteriosus closure.
Tomasulo CE; Gillespie MJ; Munson D; Demkin T; O'Byrne ML; Dori Y; Smith CL; Rome JJ; Glatz AC
Catheter Cardiovasc Interv; 2020 Oct; 96(4):889-897. PubMed ID: 32339400
[TBL] [Abstract][Full Text] [Related]
13. Is the new Occlutech duct occluder an appropriate device for transcatheter closure of patent ductus arteriosus?
Godart F; Houeijeh A; Domanski O; Guillaume MP; Brard M; Lucron H
Int J Cardiol; 2018 Jun; 261():54-57. PubMed ID: 29551254
[TBL] [Abstract][Full Text] [Related]
14. Closure of large patent ductus arteriosus using the Amplatzer Septal Occluder.
García-Montes JA; Camacho-Castro A; Sandoval-Jones JP; Buendía-Hernández A; Calderón-Colmenero J; Patiño-Bahena E; Zabal C
Cardiol Young; 2015 Mar; 25(3):491-5. PubMed ID: 24555910
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of calcified patent ductus arteriosus in older adult patients: Immediate and 12-month follow-up results.
Gu X; Zhang Q; Sun H; Fei J; Zhang X; Kutryk MJ
Congenit Heart Dis; 2017 May; 12(3):289-293. PubMed ID: 27874259
[TBL] [Abstract][Full Text] [Related]
16. Trial occlusion to assess the risk of persistent pulmonary arterial hypertension after closure of a large patent ductus arteriosus in adolescents and adults with elevated pulmonary artery pressure.
Zhang DZ; Zhu XY; Lv B; Cui CS; Han XM; Sheng XT; Wang QG; Zhang P
Circ Cardiovasc Interv; 2014 Aug; 7(4):473-81. PubMed ID: 25097200
[TBL] [Abstract][Full Text] [Related]
17. [Lung perfusion studies after percutaneous closure of patent ductus arteriosus using the Amplatzer Duct Occluder in children].
Parra-Bravo JR; Apolonio-Martínez A; Estrada-Loza Mde J; Beirana-Palencia LG; Ramírez-Portillo CI
Arch Cardiol Mex; 2015; 85(3):188-94. PubMed ID: 25700578
[TBL] [Abstract][Full Text] [Related]
18. Fate of the Left Pulmonary Artery and Thoracic Aorta After Transcatheter Patent Ductus Arteriosus Closure in Low Birth Weight Premature Infants.
Markush D; Tsing JC; Gupta S; Berndsen NC; Radville G; Garg R; Zahn EM; Almeida-Jones M
Pediatr Cardiol; 2021 Mar; 42(3):628-636. PubMed ID: 33394112
[TBL] [Abstract][Full Text] [Related]
19. The new Occlutech(®) patent ductus arteriosus occluder: Single centre experience.
Boudjemline Y
Arch Cardiovasc Dis; 2016; 109(6-7):384-9. PubMed ID: 26988839
[TBL] [Abstract][Full Text] [Related]
20. Intermediate- and long-term follow-up of device closure of patent arterial duct with severe pulmonary hypertension: factors predicting outcome.
Sadiq M; Rehman AU; Hyder N; Qureshi AU; Kazmi T; Qureshi SA
Cardiol Young; 2017 Jan; 27(1):26-36. PubMed ID: 27133447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
